By Natalie Grover (Reuters) - The U.S. Food and Drug Administration approved BioCryst Pharmaceuticals Inc's single-dose flu drug, in what the company says is the agency's first ever approval for an intravenous drug to fight influenza. The drug is intended for adults with acute uncomplicated influenza who are unable to swallow pills such as Gilead Sciences Inc's Tamiflu or inhale GlaxoSmithKline Plc's Relenza because of upper respiratory problems. ...
via Health News Headlines - Yahoo News http://ift.tt/1zUJPqp
via Health News Headlines - Yahoo News http://ift.tt/1zUJPqp
No comments:
Post a Comment